Recurrent Campylobacter jejuni bacteraemia with independent acquisition of carbapenem resistance in three ST9611 isolates: a case series in immunocompromised hosts. [PDF]
Ngiam JN +5 more
europepmc +1 more source
Eravacycline: From broad-spectrum coverage to novel clinical applications. [PDF]
Albanell-Fernández M +4 more
europepmc +1 more source
Therapeutic effect of eravacycline against carbapenem-resistant hypervirulent <i>Klebsiella pneumoniae</i> in mouse models. [PDF]
Zhang R +7 more
europepmc +1 more source
In Vitro Activity of Cefiderocol, Eravacycline, and Imipenem-Relebactam Against Multidrug-Resistant <i>Acinetobacter baumannii</i> Clinical Isolates. [PDF]
Bölükbaşı Y, Öngen B.
europepmc +1 more source
Real-World Safety and Efficacy Data Comparing Dosing Strategies of Eravacycline: A Retrospective Cohort Study. [PDF]
McCourt NM, Krsak M, Brade K, Casias M.
europepmc +1 more source
Real-world effectiveness and predictors of treatment failure for eravacycline in patients with <i>Acinetobacter baumannii</i> or <i>Klebsiella pneumoniae</i> infections: a multicenter retrospective analysis. [PDF]
Li Y, Yi Q, Zhou M, Lu M, Xu Y.
europepmc +1 more source
Efficacy of eravacycline in difficult-to-treat (DTR) Acinetobacter baumannii bacteraemia in ICU: a case report. [PDF]
Melchio M +5 more
europepmc +1 more source
Erratum: Comparative in vitro Activity and Clinical Outcomes of Eravacycline, Tigecycline, and Omadacycline Against Carbapenem-Resistant <i>Acinetobacter baumannii</i> and <i>Klebsiella pneumoniae</i> [Corrigendum]. [PDF]
europepmc +1 more source
High prevalence of bla<sub>NDM</sub> gene among a series of carbapenem-resistant Enterobacterales isolates from children less than one year old in Niger. [PDF]
Massir IN +10 more
europepmc +1 more source
Comparative in vitro Activity and Clinical Outcomes of Eravacycline, Tigecycline, and Omadacycline Against Carbapenem-Resistant <i>Acinetobacter baumannii</i> and <i>Klebsiella pneumoniae</i>. [PDF]
Chen D +11 more
europepmc +1 more source

